Cara Therapeutics Inc (STU:69C)
€ 0.2506 -0.0086 (-3.32%) Market Cap: 14.16 Mil Enterprise Value: -22.43 Mil PE Ratio: 0 PB Ratio: 20.96 GF Score: 31/100

Cara Therapeutics Inc Annual Shareholders Meeting Transcript

Jun 03, 2021 / 04:00PM GMT
Release Date Price: €10.62 (-0.65%)
Derek T. Chalmers
Cara Therapeutics, Inc. - Co-Founder, President, CEO & Director

So, good afternoon, everybody. I am Derek Chalmers, and I'm the Chief Executive Officer of Cara Therapeutics, and I'm very happy to welcome you to the Cara Therapeutics' 2021 Stockholders Meeting.

Before I call the meeting to order, I'd like to introduce to you, the other members of the Board and the business team, who are with us today on the call. The other members of the Board here in person are Dr. Jeffrey Ives, Harrison Bains, Jr., Christopher Posner, Dr. Susan Shiff, and Martin Vogelbaum, who also serves as the company's lead independent Director.

The other officers of the company here today are Thomas Reilly, our Chief Financial Officer; and Scott Terrillion, our General Counsel, Secretary and Chief Compliance Officer; and Mr. Terrillion will act as Secretary for the stockholders meeting.

I'd also like to introduce Sean Riegler and Jason Robinson of Ernst & Young LLP, the company's auditors, who are available to respond to appropriate questions.

And finally, I would like

Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis
30-Year Financial on one screen
All-in-one Stock Screener with unlimited filters
Customizable Stock Dashboard
Real Time Insider Trading Transactions
8,000+ Institutional investors’ 13F holdings
Powerful Excel Add-in and Google sheets Add-on
All data downloadable
Quick customer support
And much more...
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot